Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
A Small-Molecule Inhibitor of Isoprenylcysteine Carboxyl Methyltransferase with Antitumor Activity in Cancer Cells
by
Gooden, David M.
, Toone, Eric J.
, Winter-Vann, Ann M.
, York, John D.
, dela Cruz, June
, Casey, Patrick J.
, Baron, Rudi A.
, Young, Stephen G.
, Glomset, John A.
, Bergo, Martin O.
, Wong, Waihay
in
Acetamides - chemistry
/ Acetamides - pharmacology
/ Animals
/ Antineoplastic Agents - chemistry
/ Antineoplastic Agents - pharmacology
/ Biological Sciences
/ Cell Division - drug effects
/ Cell growth
/ Cell Line
/ Cell Line, Tumor
/ Cell lines
/ Cell Transformation, Neoplastic - drug effects
/ Colonic Neoplasms - drug therapy
/ Colonic Neoplasms - enzymology
/ Colonic Neoplasms - pathology
/ Colorectal cancer
/ Dogs
/ Enzyme Inhibitors - chemistry
/ Enzyme Inhibitors - pharmacology
/ Enzymes
/ HEK293 cells
/ Human growth
/ Humans
/ Methylation
/ Mice
/ Phenotype
/ Protein Methyltransferases - antagonists & inhibitors
/ Protein Methyltransferases - deficiency
/ Protein Methyltransferases - genetics
/ Protein Methyltransferases - metabolism
/ Proteins
/ ras Proteins - metabolism
/ Recombinant Fusion Proteins - metabolism
/ Transformed cell line
/ Vehicles
2005
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
A Small-Molecule Inhibitor of Isoprenylcysteine Carboxyl Methyltransferase with Antitumor Activity in Cancer Cells
by
Gooden, David M.
, Toone, Eric J.
, Winter-Vann, Ann M.
, York, John D.
, dela Cruz, June
, Casey, Patrick J.
, Baron, Rudi A.
, Young, Stephen G.
, Glomset, John A.
, Bergo, Martin O.
, Wong, Waihay
in
Acetamides - chemistry
/ Acetamides - pharmacology
/ Animals
/ Antineoplastic Agents - chemistry
/ Antineoplastic Agents - pharmacology
/ Biological Sciences
/ Cell Division - drug effects
/ Cell growth
/ Cell Line
/ Cell Line, Tumor
/ Cell lines
/ Cell Transformation, Neoplastic - drug effects
/ Colonic Neoplasms - drug therapy
/ Colonic Neoplasms - enzymology
/ Colonic Neoplasms - pathology
/ Colorectal cancer
/ Dogs
/ Enzyme Inhibitors - chemistry
/ Enzyme Inhibitors - pharmacology
/ Enzymes
/ HEK293 cells
/ Human growth
/ Humans
/ Methylation
/ Mice
/ Phenotype
/ Protein Methyltransferases - antagonists & inhibitors
/ Protein Methyltransferases - deficiency
/ Protein Methyltransferases - genetics
/ Protein Methyltransferases - metabolism
/ Proteins
/ ras Proteins - metabolism
/ Recombinant Fusion Proteins - metabolism
/ Transformed cell line
/ Vehicles
2005
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
A Small-Molecule Inhibitor of Isoprenylcysteine Carboxyl Methyltransferase with Antitumor Activity in Cancer Cells
by
Gooden, David M.
, Toone, Eric J.
, Winter-Vann, Ann M.
, York, John D.
, dela Cruz, June
, Casey, Patrick J.
, Baron, Rudi A.
, Young, Stephen G.
, Glomset, John A.
, Bergo, Martin O.
, Wong, Waihay
in
Acetamides - chemistry
/ Acetamides - pharmacology
/ Animals
/ Antineoplastic Agents - chemistry
/ Antineoplastic Agents - pharmacology
/ Biological Sciences
/ Cell Division - drug effects
/ Cell growth
/ Cell Line
/ Cell Line, Tumor
/ Cell lines
/ Cell Transformation, Neoplastic - drug effects
/ Colonic Neoplasms - drug therapy
/ Colonic Neoplasms - enzymology
/ Colonic Neoplasms - pathology
/ Colorectal cancer
/ Dogs
/ Enzyme Inhibitors - chemistry
/ Enzyme Inhibitors - pharmacology
/ Enzymes
/ HEK293 cells
/ Human growth
/ Humans
/ Methylation
/ Mice
/ Phenotype
/ Protein Methyltransferases - antagonists & inhibitors
/ Protein Methyltransferases - deficiency
/ Protein Methyltransferases - genetics
/ Protein Methyltransferases - metabolism
/ Proteins
/ ras Proteins - metabolism
/ Recombinant Fusion Proteins - metabolism
/ Transformed cell line
/ Vehicles
2005
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
A Small-Molecule Inhibitor of Isoprenylcysteine Carboxyl Methyltransferase with Antitumor Activity in Cancer Cells
Journal Article
A Small-Molecule Inhibitor of Isoprenylcysteine Carboxyl Methyltransferase with Antitumor Activity in Cancer Cells
2005
Request Book From Autostore
and Choose the Collection Method
Overview
Many key regulatory proteins, including members of the Ras family of GTPases, are modified at their C terminus by a process termed prenylation. This processing is initiated by the addition of an isoprenoid lipid, and the proteins are further modified by a proteolytic event and methylation of the C-terminal prenylcysteine. Although the biological consequences of prenylation have been characterized extensively, the contributions of prenylcysteine methylation to the functions of the modified proteins are not well understood. This reaction is catalyzed by the enzyme isoprenylcysteine carboxyl methyltransferase (Icmt). Recent genetic disruption studies have provided strong evidence that blocking Icmt activity has profound consequences on oncogenic transformation. Here, we report the identification of a selective small-molecule inhibitor of Icmt, 2-[5-(3-methylphenyl)-1-octyl-1H-indol-3-yl]acetamide (cysmethynil). Cysmethynil treatment results in inhibition of cell growth in an Icmt-dependent fashion, demonstrating mechanism-based activity of the compound. Treatment of cancer cells with cysmethynil results in mislocalization of Ras and impaired epidermal growth factor signaling. In a human colon cancer cell line, cysmethynil treatment blocks anchorage-independent growth, and this effect is reversed by overexpression of Icmt. These findings provide a compelling rationale for development of Icmt inhibitors as another approach to anticancer drug development.
Publisher
National Academy of Sciences,National Acad Sciences
Subject
/ Animals
/ Antineoplastic Agents - chemistry
/ Antineoplastic Agents - pharmacology
/ Cell Division - drug effects
/ Cell Transformation, Neoplastic - drug effects
/ Colonic Neoplasms - drug therapy
/ Colonic Neoplasms - enzymology
/ Colonic Neoplasms - pathology
/ Dogs
/ Enzyme Inhibitors - chemistry
/ Enzyme Inhibitors - pharmacology
/ Enzymes
/ Humans
/ Mice
/ Protein Methyltransferases - antagonists & inhibitors
/ Protein Methyltransferases - deficiency
/ Protein Methyltransferases - genetics
/ Protein Methyltransferases - metabolism
/ Proteins
/ Recombinant Fusion Proteins - metabolism
/ Vehicles
This website uses cookies to ensure you get the best experience on our website.